Skip to main content
Log in

In vitro and ex vivo effects of indobufen on red blood cell deformability

  • Short Communications
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

We have studied the effect of indobufen, a cyclo-oxygenase blocking agent which has proved useful in patients with obstructive vascular disease, on red blood cell (RBC) filterability in vitro and in a pilot study ex vivo.

The addition of indobufen in vitro to blood samples from 10 healthy volunteers did not significantly modify RBC deformability.

We evaluated the ex vivo effect of indobufen (200 mg bd) in 14 patients with obstructive vascular disease. A significant improvement in RBC deformability was noted on the 5th, 14th, and 28th days of treatment, 2 h after the morning dose. Acetylsalicylic acid given to 6 similar patients had no effect suggesting that the positive haemorheological effect of indobufen is probably not linked to its cyclooxygenase blocking effect.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Editorial (1978) Red cell deformability. Lancet 2: 1348–1349

  2. Muller R (1980) Zum gegenwärtigen Stand der Hämorheologie aus klinisch-pharmakologischer Sicht. Therapiewoche 30: 2440–2451

    Google Scholar 

  3. Palinski W, Torsellini A, Doni L (1983) Influence of platelet activation on erythrocyte deformability. Thromb Haemostas 49: 84–86

    Google Scholar 

  4. Reid HL, Dormandy JA, Barnes AJ, Locke PJ, Dormandy TL (1976) Impaired red cell deformability in peripheral vascular disease. Lancet 1: 666–667

    Google Scholar 

  5. Schmid-Schöbein H, Volger E (1976) Red cell aggregation and red cell deformability in diabetes. Diabetes 25 [Suppl 2]: 897–902

    Google Scholar 

  6. Dodds AJ, O'Reilly MJG, Yates CJP, Cotton LT, Flute PT, Dormandy JA (1979) Haemorheological response to plasma exchange in Raynaud's syndrome. Br Med J 2: 1186

    Google Scholar 

  7. Horne McDK (1981) Sickle cell anemia as a rheological disease. Am J Med 70: 288–298

    Google Scholar 

  8. Saruta S (1981) Blood filterability in cerebrovascular disorders with special reference to erythrocyte deformability. Stroke 126: 824–828

    Google Scholar 

  9. Gresele P, Guerciolini R, Nenci GG (1982) Erythrocyte deformability changes in normal pregnancy and preeclampsia. Br J Haematol 52: 340–342

    Google Scholar 

  10. Dodds AJ, Boyd MJ, Allen J, Bennet CD, Flute PT, Dormandy JA (1980) Changes in red cell deformability and other haemorheological variables following myocardial infarction. Br Heart J 44: 508–511

    Google Scholar 

  11. Ono S, Ashida S, Abiko Y (1981) Haemorheological effect of ticlopidine in rats. Thromb Haemostas 46: 176

    Google Scholar 

  12. Sowemimo-Coker SO, Kovacs IB, Pickles H, Hedges A, Turner P (1983) Dipyridamole increases red cell deformability. Br J Clin Pharmacol 16: 423–425

    Google Scholar 

  13. Guerciolini R, Merante F, Gresele P, Grasselli S, Susani L, Nenci GG (1986) Effect of different plasma expanders on erythrocyte filterability. Clin Haemorheol 6: 511–521

    Google Scholar 

  14. Italian Multicenter Study Group (1985) Long-term antiplatelet activity and safety of indobufen in patients with cardiovascular disease. Intern J Clin Pharmacol Ther Toxicol 8: 439–446

    Google Scholar 

  15. Reid HL, Barnes AJ, Lock PJ, Dormandy JA, Dormandy TL (1976) A simple method for measuring erythrocyte deformability. J Clin Pathol 29: 855–859

    Google Scholar 

  16. Schafer AI, Handin RI (1979) The role of platelets in thrombotic and vascular disease. Progr Cardiovasc Dis 22: 31–52

    Google Scholar 

  17. Ulutin ON, Ozer M, Sari H, Akcam B, Ozdacaci T, Urgancioglu I, Balkuv-Ulutin S (1982) The effect of indobufen on the peripheric obliterative vascular diseases. Haemostasis 12: 181

    Google Scholar 

  18. Tamassia V, Corvi G, Fuccella LM, Moro E, Tosolini G, Tremoli E (1979) Indobufen (K 3920), a new inhibitor of platelet aggregation: Effect of food on bioavailability, pharmacokinetic and pharmacodynamic study during repeated oral administration to man. Eur J Clin Pharmacol 15: 329–333

    Google Scholar 

  19. Vittoria A, Laghi Pasini E, Messa GL, Di Perri T, Corvi G, Fuccella LM (1981) Inhibition of platelet aggregation in man by indobufen (K 3920). Int Med Res 9: 12

    Google Scholar 

  20. Pfafferott C, Meiselman HJ, Mochstein P (1982) The effect of malonyldialdehyde on erythrocyte deformability. Blood 59: 12–15

    Google Scholar 

  21. Dowd PM, Kovacs IB, Bland CJH, Kirby JDT (1981) Effect of prostaglandins I2 and E1 on red cell deformability in patients with Raynaud's phenomenon and systemic sclerosis. Br Med J 283: 350

    Google Scholar 

  22. Kovack IB, O'Grady J (1984) Prostacyclin increases filterability on normal and rigidified human red blood cells in vitro. Agent Action 14: 306–310

    Google Scholar 

  23. Slott JH, Hall K, Clark DA, Stuart MJ (1982) Prostaglandin I2 fails to influence red cell deformability. Prostaglandins Leukotrienes Med 8: 21

    Google Scholar 

  24. Belch JJF, Lowe GDO, Drummond MM, Forbes CD, Prentice CRM (1981) Prostacyclin reduces red cell deformability. Thromb Haemost 45: 189

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grasselli, S., Guerciolini, R., Iadevaia, V. et al. In vitro and ex vivo effects of indobufen on red blood cell deformability. Eur J Clin Pharmacol 32, 207–210 (1987). https://doi.org/10.1007/BF00542198

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00542198

Key words

Navigation